Parallel Industries Inc. (EAPH) est une société cotée en bourse dans le Santé secteur, opérant dans le Drug Manufacturers - Specialty & Generic secteur d'activité. Le siège social de l'entreprise est situé à Toronto, ON, Canada. Le PDG actuel est Evan Karras.
EAPH a date d'introduction en bourse 1999-09-13, 6 employés à temps plein, cotée sur le Other OTC, une capitalisation boursière de $9.33K.
Parallel Industries Inc. does not have significant operations. Previously, the company was involved in development and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. It focuses on development, licenses, production, and markets prescription and over-the-counter products. The company was formerly known as Easton Pharmaceuticals Inc. and changed its name to Parallel Industries Inc. in December 2020. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada.
